MedAdvisor, Zuellig Pharma in JV to market medication management solutions in Asia

📆 07-05-19 10:47:00
📰 BusinessTimes

⏱ Reading Time:
12 sec. here
2 min. at publisher
📊 Quality Score:
News: 8%
Publisher: 51%

Belgique Nouvelles Nouvelles

Belgique Dernières Nouvelles,Belgique Actualités

AUSTRALIAN medication platform MedAdvisor and healthcare service provider Zuellig Pharma have formed a 50:50 Singapore-based joint venture (JV) ZP MedAdvisor (ZPM) to commercialise MedAdvisor’s platform across Asia. Read more at The Business Times.

AUSTRALIAN medication platform MedAdvisor and healthcare service provider Zuellig Pharma have formed a 50:50 Singapore-based joint venture ZP MedAdvisor to commercialise MedAdvisor’s platform across Asia.

ZPM has signed a software licence agreement for its medication management solutions on an exclusive basis for eight key markets - Singapore, Thailand, Indonesia, South Korea, Taiwan, Hong Kong, the Philippines and Malaysia.

Écrire un Commentaire

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

Belgique Dernières Nouvelles, Belgique Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

South-east Asia stocks end weaker as Trump threat jolts markets, Singapore divesBENGALURU — South-east Asian stocks closed lower on Monday (May 6) after US President Donald Trump threatened to hike tariffs on Chinese goods this week, rekindling trade tensions between Washington and Beijing, with Singapore leading the losses in the region.
La source: TODAYonline - 🏆 1. / 99 Lire la suite »